Q
Qiang Liu
Researcher at Tsinghua University
Publications - 836
Citations - 29296
Qiang Liu is an academic researcher from Tsinghua University. The author has contributed to research in topics: Medicine & Laser. The author has an hindex of 60, co-authored 652 publications receiving 20634 citations. Previous affiliations of Qiang Liu include Northeast Petroleum University & Guangdong University of Technology.
Papers
More filters
Journal ArticleDOI
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
TL;DR: The latest progress in m6A RNA methylation research is reviewed and its regulation on BC occurrence and development is investigated to find out if it affects clinical treatments in elderly patients.
Journal ArticleDOI
UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer.
TL;DR: It is found that UHRF1 was highly expressed in human ATC compared with normal tissue and papillary thyroid cancer (PTC), and UHRf1 knockdown reduced the transcription of cytokines, which might relieve the inflammatory reaction in ATC patients.
Journal ArticleDOI
Radiation-direction steerable nanoantennae
TL;DR: In this paper, a reflection nano-antenna with a metasurface containing an array of silver nanoparticles is designed, and an electro-optical layer is introduced to produce radiation-direction steerability.
Proceedings ArticleDOI
The test of the 10k x 10k CCD for Antarctic Survey Telescopes (AST3)
Bin Ma,Zhaohui Shang,Lifan Wang,Lifan Wang,Kasey Boggs,Yi Hu,Qiang Liu,Qian Song,Suijian Xue +8 more
TL;DR: In this article, a 10k x 10k single-chip CCD camera was installed on the first Antarctic Survey Telescope (AST3-1) at Dome A, Antarctica in January 2012.
Journal ArticleDOI
Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapy
Linnan Yang,Linnan Yang,Feng Li,Yongsheng Cao,Qiang Liu,Guoxin Jing,Jintong Niu,Feiyue Sun,Yechang Qian,Shilong Wang,Ang Li +10 more
TL;DR: Wang et al. as discussed by the authors developed a novel nanocomposite, polyethyleneimine-modified dendritic mesoporous silica nanoparticles loaded with microRNA-125a (DMSN-PEI@125a) to synergistically enhance immune response and immunosuppression reversion, ultimately generating a tumoricidal environment.